Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Genasys Inc is a scientific & technical instruments business based in the US. Genasys shares (GNSS) are listed on the NASDAQ and all prices are listed in US Dollars. Genasys employs 148 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $3.33 |
|---|---|
| 52-week range | $2.40 - $5.89 |
| 50-day moving average | $3.26 |
| 200-day moving average | $3.88 |
| Wall St. target price | $6.88 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.02 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.33 from 2022-06-29
| 1 week (2022-06-24) | -11.20% |
|---|---|
| 1 month (2022-06-01) | -13.51% |
| 3 months (2022-03-29) | 19.78% |
| 6 months (2021-12-31) | -16.33% |
| 1 year (2021-07-01) | -41.78% |
|---|---|
| 2 years (2020-07-01) | -30.19% |
| 3 years (2019-07-01) | 3.45 |
| 5 years (2017-06-30) | 95.88% |
Valuing Genasys stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Genasys's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Genasys's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.6 million.
The EBITDA is a measure of a Genasys's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $51.5 million |
|---|---|
| Gross profit TTM | $23.4 million |
| Return on assets TTM | -0.59% |
| Return on equity TTM | -1.25% |
| Profit margin | -1.43% |
| Book value | $1.77 |
| Market capitalisation | $132 million |
TTM: trailing 12 months
We're not expecting Genasys to pay a dividend over the next 12 months.
Over the last 12 months, Genasys's shares have ranged in value from as little as $2.4 up to $5.89. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Genasys's is 0.3516. This would suggest that Genasys's shares are less volatile than average (for this exchange).
Genasys Inc. a global provider of critical communications hardware and software solutions worldwide. The company operates through two segments, Hardware and Software. It provides long range acoustic devices, such as acoustic hailing devices which are used to project sirens and audible voice messages; and Genasys Emergency Management, a software-based product line. The company also offers National Emergency Warning Systems, a software application that works with mobile carriers to send emergency communications to the public; Integrated Mass Notification Systems, an emergency response solution, uniting GEM Software and Genasys speaker system hardware; and GEM software to emails, voice calls, text messages, panic buttons, desktop alerts, television, social media, and others. It sells its products directly to governments, militaries, end-users, and commercial companies. The company was formerly known as LRAD Corporation.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.